Summary & Overview
HCPCS G9293: Pathology Report Missing Thickness, Ulceration, or Mitotic Rate
HCPCS Level II code G9293 denotes a pathology report that lacks key elements: patient category, tumor thickness and ulceration statement, and for pT1 tumors, mitotic rate. These pathologic features are pivotal for accurate staging, prognosis, and downstream treatment decisions for cutaneous malignancies. Nationally, consistent pathology reporting supports appropriate care pathways and accurate claims adjudication.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis covers payer applicability and common considerations for documentation-driven billing reviews.
Readers will learn what G9293 represents clinically and operationally, why completeness of pathology reports matters for staging and reimbursement, and what benchmarks and policy context typically surround documentation-driven HCPCS reporting. Content addresses clinical context for pathologists and coding professionals, common service settings where the code is relevant, and how missing elements affect downstream coding and case management. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9293 indicates that a pathology report is missing specific required elements: patient category, a statement on tumor thickness and ulceration, and — for pT1 lesions — mitotic rate. This code applies to pathology documentation related to cutaneous malignant neoplasms where staging and prognostic features are essential to clinical management.
Service type: Pathology / Surgical Pathology Documentation Review
Typical site of service: Hospital-based pathology laboratories, independent pathology laboratories, and outpatient surgical centers where specimens are processed and reports are generated.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents to a dermatology clinic with a suspicious pigmented skin lesion on the upper back. The lesion was excised in an outpatient dermatologic procedure under local anesthesia and submitted to surgical pathology for definitive diagnosis and staging. The pathology report returned as invasive melanoma but the report omitted the patient (pt) category, measurement of tumor thickness (Breslow depth) and ulceration status — essential elements for staging — and, for lesions meeting the pT1 category, the mitotic rate. The clinical workflow includes specimen reception, gross description, histologic processing, microscopic examination, and report generation. When key staging elements are missing, the surgical team may request an amended pathology report or addendums to document pt category, Breslow thickness, ulceration presence/absence, and mitotic rate if applicable. Typical site of service is an outpatient dermatology clinic or ambulatory surgical center with submission to a pathology laboratory. Common payors involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when service complexity or time is substantially greater than typical for the procedure, as documented in the record. |